ZECHENG ELECTRONICS
837821
Ji Yao Holding Group
300108
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Hajime Advanced Material Technology
301000
CN Stock MarketDetailed Quotes
688117 ChengDu Sheng Nuo Biotec
- 23.76
- 0.000.00%
Market Closed Jan 9 15:00 CST
2.67BMarket Cap28.87P/E (TTM)
24.10High23.50Low10.99KlotVolume23.69Open23.76Pre Close26.20MTurnover0.98%Turnover Ratio37.96P/E (Static)112.42MShares36.9852wk High2.89P/B2.67BFloat Cap16.2652wk Low28.51Limit Up112.42MShs Float57.26Historical High19.01Limit Down2.53%Amplitude14.38Historical Low0.20Dividend TTM23.84Avg Price6.26KlotAsk0.84%Div YieldTTM100Lot Size4.22KlotBid
ChengDu Sheng Nuo Biotec News
Shengnuo Biotech: Announcement on the results of shareholding reduction results for shareholders holding 5% or more of shares
Announcement on the results of reducing shareholdings by shareholders holding 5% or more of the shares
Shengnuo Biotech: Report of Minsheng Securities Co., Ltd. on Chengdu Shengnuo Biotechnology Co., Ltd.\'s continuous supervision and regular on-site inspection in 2024
Report of Minsheng Securities Co., Ltd. on the 2024 continuous supervision and regular on-site inspection report of Chengdu Shengnuo Biotechnology Co., Ltd.
Shengnuo Biotech: Announcement of Resolutions of the 23rd Meeting of the 4th Board of Supervisors
Shengnuo Biotech: Announcement on the Company and Actual Controllers Providing Guarantees for Wholly-owned Subsidiaries to Apply for Comprehensive Bank Credit Lines
Shengnuo Biotech: Minsheng Securities Co., Ltd.\'s inspection opinion on Chengdu Shengnuo Biotechnology Co., Ltd. and the actual controller providing guarantees for wholly-owned subsidiaries to apply for comprehensive bank credit lines
Shengnuo Biotech: Articles of Association (December 2024)
Shengnuo Biopharmaceutical Co., Ltd.: Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Shengnuo Biotech: Vesting Results and Stock Listing Announcement on the First Term of the 2023 Restricted Stock Incentive Plan and Part of the Reservation Grant
Shengnuo Biotech: Notice on Changing the Company\'s Registered Capital, Revising the “Articles of Association”, and Registering Industrial and Commercial Changes
Announcement on the ownership results of the first vesting period of the 2023 Restricted Stock Incentive Plan and the first part of the reservation grant and share listing
Minsheng Securities Co., Ltd.\'s inspection opinion on Chengdu Shengnuo Biotechnology Co., Ltd. and the actual controller providing guarantees for wholly-owned subsidiaries to apply for comprehensive bank credit lines
Basic information on Chengdu Shengnuo Biopharmaceutical Co., Ltd. and financial statements of June 30, 2024
Announcement of Resolutions of the 23rd Meeting of the Fourth Board of Supervisors
Articles of Association (December 2024)
Notice on changing the registered capital of the company, amending the “Articles of Association”, and applying for registration of industrial and commercial changes
Notice on the Company and Actual Controllers Providing Guarantees for Wholly-owned Subsidiaries to Apply for Comprehensive Bank Credit Lines
Shengnuo Biotech: Simplified Equity Change Report (Lepu Healthcare)
Shengnuo Biotech: Notice on the Controlling Shareholder Agreement to Transfer Part of the Company\'s Shares and Complete Transfer Registration